Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM

Clinical trial NCT06352866 · WITHDRAWN

Trial details

NCT number: NCT06352866
Sponsor: Jack Khouri, MD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Cytokine Release Syndrome Refractory Multiple Myeloma Immune Effector Cell Associated Neurotoxicity Syndrome

Start date: 2025-01-01
Primary completion: 2025-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.